Treatment of primary cutaneous lymphoma with reference to the latest therapeutic consensus of the Polish Lymphoma Research Group (PLRG)

Postepy Dermatologii i Alergologii

Volumn 29, Issue 2, 2012, Pages 63-68

  Wojewoda, Karolina ^a   Brenner, Jonas ^a   Sokołowska Wojdyło, Małgorzata ^a   Barańska Rybak, Wioletta ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Cutaneous T cell lymphomas; Mycosis fungoides; S zary syndrome

Indexed keywords

BEXAROTENE; CARMUSTINE; CHLORAMBUCIL; CLADRIBINE; CORTICOSTEROID; CYTARABINE; DENILEUKIN DIFTITOX; DOXORUBICIN; ETOPOSIDE; ETRETIN; GEMCITABINE; METHOTREXATE; RECOMBINANT ALPHA INTERFERON; RETINOID; ROMIDEPSIN; STEROID; VORINOSTAT;

ADULT; AGED; AGRANULOCYTOSIS; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CONSENSUS; CUTANEOUS T CELL LYMPHOMA; FEMALE; HODGKIN DISEASE; HOSPITALIZATION; HUMAN; LOW DRUG DOSE; LYMPHOMATOID PAPULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MUCOSAL DISEASE; MYCOSIS FUNGOIDES; NEUTROPENIA; PHOTOTHERAPY; POLAND; PUVA; SEPSIS; SEZARY SYNDROME; SKIN DEFECT; STEVENS JOHNSON SYNDROME; ULCER; ULTRAVIOLET B RADIATION;

EID: 84860330707     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768-85. (Pubitemid 40656118)
2. Braun-Falco O, Plewig G, Wolff HH, Burgdorf WHC. Malignant lymphomas. Dermatology. Second Completely Revised Edition. Bischoff W(ed.). Springer-Verlag, Munich and Lubeck 2000; 1617-9.
3. Hubert JN, Callen JP. Recalcitrant tinea corporis as the presenting manifestation of patch-stage mycosis fungoides. Cutis 2003; 71: 59-61. (Pubitemid 38010848)
4. Girardi M, Heald PW, Wilson LD, et al. The pathogenesis of mycosis fungoides. N Engl J Med 2004; 350: 1978-88. (Pubitemid 38580201)
5. Wieselthier JS, Koh HK. Sézary syndrome: diagnosis, prognosis and critical review of treatment options. J Am Acad Dermatol 1990; 22: 381-401. (Pubitemid 20212390)
6. Scarisbrick JJ, Whittaker S, Evans AV, et al. Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma. Blood 2001; 97: 624-30. (Pubitemid 32113393)
7. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer (EORTC). Blood 1997; 90: 354-71. (Pubitemid 27276581)
8. Bekkenk M, Geelen FA, van Voorst Vader PC, et al. Primary and secondary cutaneous CD30-positive lymphoproliferative disorders: long term follow-up data of 219 patients and guidelines for diagnosis and treatment: a report from the Dutch Cutaneous Lymphoma Group. Blood 2000; 95: 3653-61. (Pubitemid 30412833)
9. Braun-Falco O, Plewig G, Wolff HH, Burgdorf WHC. Chłoniaki. [In:] Dermatologia. Braun-Falco O, Plewig G, Wolff HH, Burgdorf WHC (eds). Czelej, Lublin 2004; 1509-40.
10. Zackheim HS, Kashani-Sabet M, Amin S. Topical corticosteroids for mycosis fungoides. Experience in 79 patients. Arch Dermatol 1998; 134: 949-54. (Pubitemid 28385316)
11. Herrmann JJ, Roenigk HH Jr, Hurria A, et al. Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up. J Am Acad Dermatol 1995; 33: 234-42.
12. Carter J, Zug KA. Phototherapy for cutaneous T-cell lymphoma: online survey and literature review. J Am Acad Dermatol 2009; 60: 39-50.
13. Zackheim HS, Kashani-Sabet M, McMillan A. Low-dose methotrexate to treat mycosis fungoides: a retrospective study in 69 patients. J Am Acad Dermatol 2003; 49: 873-8. (Pubitemid 37314876)
14. McDonald CJ, Bertino JR. Treatment of mycosis fungoides lymphoma: effectiveness of infusions of methotrexate followed by oral citrovorum factor. Cancer Treat Rep 1978; 62: 1009-14. (Pubitemid 8405988)
15. Sokołowska-Wojdyło M, Lech-Marańda E, Placek W, et al. Leczenie pierwotnych chłoniaków skóry. Rekomendacje Sekcji Chłoniaków Skóry Polskiej Grupy Badawczej Chłoniaków (PLRG). Onkol Prakt Klin 2010; 6: 29-47.
16. Kaye FJ, Bunn PA Jr, Steinberg SM, et al. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med 1989; 321: 1784-90. (Pubitemid 20015571)
17. Prince HM, Whittaker S, Hoppe RT. How we treat mycosis fungoides and Sezary syndrome. Blood 2009; 114: 4337-53.
18. Huber MA, Staib G, Pehamberger H, Scharffetter-Kochanek K. Management of refractory early-stage cutaneous T-cell lymphoma. Am J Clin Dermatol 2006; 7: 155-69. (Pubitemid 43845340)
19. Abbott RA, Whittaker SJ, Morris SL, et al. Bexarotene therapy for mycosis fungoides and Sezary syndrome. Br J Dermatol 2009; 160: 1299-307.
20. Gniadecki R, Assaf C, Bagot M, et al. The optimal use of bexarotene in cutaneous T-cell lymphoma. Br J Dermatol 2007; 157: 433-40. (Pubitemid 47256108)
21. Batycka-Baran A, Reich A, Konsur-Jankowska A, Maj J. New trends in the management of mycosis fungoides and Sezary syndrome. Post Dermatol Alergol 2009; 26: 41-55.
22. Yu JB, Khan AM, Jones GW, et al. Patients perspectives regarding the value of total skin beam therapy for cutaneous Y-cell lymphoma mycosis fungoides: a pilot study. Am J Clin Oncol 2009; 32: 142-4.
23. Goujon E, Truc G, Petrella T, et al. Total skin electron beam therapy for early-stage mycosis fungoides: immediate results and long-term follow-up in 68 patients. Ann Dermatol Venereol 2009; 136: 249-55.
24. Duarte RF, Canals C, Onida F, et al. Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol 2010; 28: 4492-9.